← Back to Search

ChatGPT for Educational Activities in Health Sciences Students (AIHSS Trial)

N/A
Waitlist Available
Led By Mirella Veras, PhD
Research Sponsored by Carleton University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Unable to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 24 hours
Awards & highlights

Summary

This trial compares an intervention (ChatGPT) to usual online resources to see which works better.

Who is the study for?
This trial is for health science students enrolled in the HLTH 3503 course, focusing on Chronic Health Conditions and Disability for Fall 2023. Participants must be able to give informed consent. Those who cannot provide this consent are excluded.Check my eligibility
What is being tested?
The study is testing the effectiveness of ChatGPT as an educational tool against usual online resources. It's a crossover randomized control trial where students are randomly placed into two groups: one using ChatGPT and another with standard materials.See study design
What are the potential side effects?
Since this trial involves educational tools rather than medical interventions, 'side effects' may include differences in learning outcomes or preferences rather than physical symptoms.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
System Usability Scale (SUS) scores are 0-100,The average SUS score is 68.
Secondary outcome measures
Student's perception of artificial intelligence, questionnaire reviwed by experts, No recognised gold standard measurement for outcome.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Artificial Intelligence (ChatGPT) GroupExperimental Treatment1 Intervention
Participants in Group A will be assigned to utilize ChatGPT as their tool to complete assignments. They will be given a period of six days to utilize artificial intelligence through ChatGPT for assignment completion. Along with the assignment instructions, participants will receive an ethical guideline and specific guidelines on how to effectively utilize ChatGPT. Once the intervention period is concluded, participants will be given a 24-hour window to complete a survey that assesses the usability of the technology. The survey aims to gather valuable feedback on the participants' experience and perception of using ChatGPT for their assignments. In addition, participants in Arm 1 will also be asked to fill out a survey regarding their perception of using artificial intelligence (AI) as an assistance tool to complete their assignments. This survey aims to gather insights into their thoughts, opinions, and attitudes towards utilizing AI in the learning process
Group II: Traditional Online tools GroupActive Control1 Intervention
Group B will serve as the control group in this study. Participants in this group will receive instructions on how to complete the assignment using traditional online tools available on the internet, without the use of artificial intelligence. They will have a timeframe of six days to complete the assignment using these conventional tools. Similar to participants in Arm 1, they will also be required to fill out a survey on technology usability, providing feedback on their experience with the online tools.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments involving Artificial Intelligence, such as those studied in the ChatGPT trial, primarily focus on providing information, support, and guidance. These AI systems use natural language processing and machine learning algorithms to understand and respond to patient queries, offering personalized advice and emotional support. This matters for patients as it enhances accessibility to reliable health information, supports decision-making, and can provide timely emotional support, potentially improving overall patient outcomes and satisfaction.
Application of Artificial Intelligence on Psychological Interventions and Diagnosis: An Overview.Future thinking to decrease real-world drinking in alcohol use disorder: Repairing reinforcer pathology in a randomized proof-of-concept trial.

Find a Location

Who is running the clinical trial?

Carleton UniversityLead Sponsor
2 Previous Clinical Trials
142 Total Patients Enrolled
Université de MontréalOTHER
218 Previous Clinical Trials
103,072 Total Patients Enrolled
Mirella Veras, PhDPrincipal InvestigatorCarleton University

Media Library

Artificial Intelligence (ChatGPT) Group Clinical Trial Eligibility Overview. Trial Name: NCT05963802 — N/A
Artificial Intelligence Research Study Groups: Traditional Online tools Group, Artificial Intelligence (ChatGPT) Group
Artificial Intelligence Clinical Trial 2023: Artificial Intelligence (ChatGPT) Group Highlights & Side Effects. Trial Name: NCT05963802 — N/A
Artificial Intelligence (ChatGPT) Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05963802 — N/A
~14 spots leftby Jul 2025